We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Gets Favorable Ruling Against Mylan in Azilect Generic Battle
Teva Gets Favorable Ruling Against Mylan in Azilect Generic Battle
September 30, 2013
A federal judge has upheld Teva’s patent for Azilect, striking down a claim from Mylan and possibly ending a long legal battle surrounding the Parkinson’s disease drug.